Skip to main content

Year: 2023

Petrus Resources Announces Third Quarter 2023 Financial & Operating Results, Declares First Regular Monthly Dividend

CALGARY, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to report financial and operating results as at and for the three and nine months ended September 30, 2023. Q3 2023 HIGHLIGHTS:Production up 49% – Production was up 49% from 6,639 boe/d(1) in the third quarter of 2022 to 9,880 boe/d in the third quarter of 2023 as a result of the new wells brought on production in late 2022 and 2023. Consistent with its 2023 revised budget guidance, Petrus has maintained relatively flat production year to date, averaging 10,580 boe/d(1). Operating expense down 21% – Operating expense was $6.70/boe in the third quarter of 2023, a decrease of 21% from $8.47/boe in the third quarter of 2022. The decrease per boe is due to Petrus’ strategic advantage in owning and operating...

Continue reading

Altus Group to Acquire APAC-Focused Valuation Software Provider Forbury

Strengthening CRE Valuation Offer in APAC Region TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus” or “the Company”) (TSX: AIF), a leading provider of asset and fund intelligence for commercial real estate (“CRE”), announced today that it signed a definitive agreement to acquire the business of Forbury Property Valuation Solutions Limited (“Forbury”), a CRE valuation software provider in the Asia Pacific (“APAC”) region. Forbury’s cloud-based solutions provide valuation tools tailored for the APAC market to help users make informed decisions on when best to refinance, refurbish, reposition or divest their CRE assets. Trusted by the market for over a decade across various asset classes, its flagship Forbury Commercial product is widely adopted for commercial property valuation in the APAC region. “The addition...

Continue reading

New York REIT Liquidating LLC Announces Results for the Quarter Ended September 30, 2023 and Declaration of Distribution of $0.15 Per Unit

NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) — New York REIT Liquidating LLC (the “Company” or the “LLC”), which was formed to complete the liquidation of the assets previously held by New York REIT, Inc., announced today it has filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023. Distributions On November 6, 2023, the Company declared a cash liquidating distribution of $0.15 per unit to be paid on November 20, 2023 to unitholders of record as of November 13, 2023. Based on currently projected future cash flows, the Company does not anticipate paying regular quarterly distributions for the foreseeable future. Future liquidating distributions will depend on, among other things, the timing and amount of cash flow distributions from our interest in Worldwide Plaza or the release of our reserves. Distributions...

Continue reading

Osisko Development Reports Third Quarter 2023 Results

Figure 1Breakthrough of the Trixie Brandy Lee decline to 625 ft. level achieved in September 2023Figure 2Cariboo Gold Project – Permitting Timeline Summary(All monetary references are expressed in Canadian dollars, unless otherwise indicated) MONTREAL, Nov. 08, 2023 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to report its financial and operating results for the three months ended September 30, 2023 (“Q3 2023“). Q3 2023 HIGHLIGHTS Operating, Financial and Corporate Updates:3,867 ounces of gold sold by the Company from operating activities, comprising of:1,776 ounces of gold sold from the Trixie test mine (“Trixie“) located within the Company’s wider Tintic Project; 803 ounces of gold...

Continue reading

CEMATRIX Announces Record Third Quarter 2023 Financial Results

Revenue of $20.4 million, 76% increase compared to Q3 2022 and a return to positive adjusted EBITDA CALGARY, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a North American leading manufacturer and supplier of technologically advanced cellular concrete products announced the release of its consolidated financial results for the quarter and year to date ending September 30, 2023. “This quarter’s financial results were the best in the history of the Company. Record revenue, strong margins, and a return to positive adjusted EBITDA, not only in the third quarter but for the first nine months of 2023. The third quarter is traditionally the strongest quarter as a result of the seasonality of construction work due to the impact of winter in...

Continue reading

Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update

TPST-1120 demonstrates superiority compared to standard of care across multiple study endpoints in randomized first-line HCC study New capital strengthens balance sheet and extends cash runway into 2025BRISBANE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and immune-mediated mechanisms, today reported financial results for the third quarter ended September 30, 2023 and provided a corporate update. “We were extremely pleased to see the pronounced external validation of the new data showing the clear benefit of TPST-1120 combination therapy compared to standard of care in first-line liver cancer,” said Stephen Brady, president and chief executive officer of Tempest. “The data have not only...

Continue reading

Atlanticus Reports Third Quarter 2023 Financial Results

Third Quarter 2023 Receivables growth of 18.1% over prior year, with over 3.4 million accounts served (1), allowing for continued strong results ATLANTA, Nov. 08, 2023 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (Atlanticus, the Company, we, our or us), a financial technology company which enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced its financial results for the third quarter ended September 30, 2023. An accompanying earnings presentation is available in the Investors section of the Company’s website at www.atlanticus.com or by clicking [here]. Financial and Operating Highlights Third Quarter 2023 Highlights (all comparisons to the Third Quarter 2022)Managed receivables2 increased 12.9% to $2.3 billion Total...

Continue reading

Osisko Declares Fourth Quarter 2023 Dividend

MONTREAL, Nov. 08, 2023 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX & NYSE) is pleased to announce a fourth quarter 2023 dividend of C$0.06 per common share. The dividend will be paid on January 15, 2024 to shareholders of record as of the close of business on December 29, 2023. This dividend is an “eligible dividend” as defined in the Income Tax Act (Canada). For shareholders residing in the United States, the U.S. dollar equivalent will be determined based on the daily rate published by the Bank of Canada on December 29, 2023. The Company also wishes to remind its shareholders that it has implemented a dividend reinvestment plan (the “Plan”). Shareholders who are residents of Canada and the United States may elect to participate in the Plan in connection with the dividend...

Continue reading

Firm Capital Apartment REIT Reports Q3/2023 Results and Provides Strategic Review Update

All figures in $USD unless otherwise noted. TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) — Firm Capital Apartment Real Estate Investment Trust (“the “Trust”), (TSXV: FCA.U), (TSXV: FCA.UN) is pleased to report its financial results for the three and nine months ended September 30, 2023 as well as provide an update regarding the previously announced Strategic Review: EARNINGSFor the three months ended September 30, 2023, net loss was approximately $1.5 million, in comparison to the $1.9 million net loss reported for the three months ended June 30, 2023 and the $1.4 million net loss reported for the three months ended September 30, 2022; Excluding non-cash fair value adjustments, net loss was $0.4 million for the three months ended September 30, 2023, in comparison to the $0.2 million net loss reported for the three months ended June...

Continue reading

Jasper Therapeutics to Participate at Upcoming Medical and Investor Conferences

REDWOOD CITY, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on the development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU), as well as lower to intermediate risk myelodysplastic syndromes (LR-MDS) and novel stem cell transplant conditioning regimens, today announced that it will participate at the following upcoming medical and investor conferences in November: American College of Allergy, Asthma, and Immunology (ACAAI) 2023 Annual Scientific MeetingConference Dates: November 9-13, 2023Abstract Title: Briquilimab, an anti-CD117 antibody, prevents passive systemic anaphylaxis in mice expressing chimeric human/mouse...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.